Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 "ASPECT-2"

Completed

Phase N/A Results

Summary of Purpose

To determine the long term efficacy of aspirin and oral anticoagulants in reducing ischemic events after acute coronary events.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 May 2003.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • The Netherlands National Health Insurance Fund Council

Trial Design

Prospective, multicenter, randomized open-label trial.

Contacts

  • University Center Utrecht PO Box 85500 3508 GA Utrect, Netherlands

    d.e.grobbee@jc.azu.nl